Cornerstone Investment Partners »

Supernus Pharmaceuticals shares owned by Cornerstone Investment Partners

Quarter-by-quarter ownership of Supernus Pharmaceuticals (SUPN) shares owned by Cornerstone Investment Partners from 13F filings

Historical chart of Cornerstone Investment Partners investment in Supernus Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Supernus Pharmaceuticals held by Cornerstone Investment Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Supernus Pharmaceuticals by Cornerstone Investment Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $267k 5.2k 51.69

More positions owned by Cornerstone Investment Partners

Alphabet Inc Class A cs (GOOGL)
KLA-Tencor Corporation (KLAC)
Applied Materials (AMAT)
Taiwan Semiconductor Adr (TSM)
Broadcom (AVGO)
Facebook Inc cl a (META)
Micron Technology (MU)
Visa (V)
AmerisourceBergen (COR)
Amazon (AMZN)
McKesson Corporation (MCK)
Chubb (CB)
Iqvia Holdings (IQV)
Diamondback Energy (FANG)
W.R. Berkley Corporation (WRB)

View all positions for Cornerstone Investment Partners

Top funds holding Supernus Pharmaceuticals

BlackRock
Vanguard Group
Millennium Management
Vanguard Portfolio Management
Vanguard Capital Management
Dimensional Fund Advisors
State Street Corporation
Nomura Asset Management International
Armistice Capital
Renaissance Technologies
Geode Capital Management
Citadel Advisors
Loomis, Sayles and
Stephens Investment Management Group
Point72 Asset Management

View all funds holding Supernus Pharmaceuticals